Literature DB >> 27602186

Effect of Phenobarbital on Nitric Oxide Level in Term Newborn Infants with Perinatal Asphyxia.

Abolfazl Khoshdel1, Hajar Noormohammadi2, Soleiman Kheiri1, Roya Reisi2, Seyed Mohammad-Kazem Nourbakhsh3, Gholam Reza Panahandeh2, Esfandiar Heidarian1.   

Abstract

OBJECTIVES: Perinatal asphyxia (PA) is very significant in perinatal medicine due to the involvement of the central nervous system. This study was conducted to investigate the biochemical, clinical, and paraclinical changes associated with phenobarbital administration in neonates with PA.
METHODS: In this prospective, case-control study, 30 neonates with PA in two groups of 15 each (case and control) were investigated. The case group received 20 mg/kg intravenous phenobarbital within six hours of birth, and the control group did not receive phenobarbital. Serum concentrations of nitric oxide (NO) were measured at enrollment and one week after birth in the two groups. Clinical, electroencephalography, and magnetic resonance imaging findings of the two groups were compared.
RESULTS: At enrollment, the two groups did not differ in clinical severity, seizure incidence, or NO concentration. After one week, NO concentration was significantly lower in the case group (p < 0.050), but there was no significant difference in other variables between the two groups.
CONCLUSIONS: Early administration of phenobarbital in term neonates with PA could protect them against encephalopathy.

Entities:  

Keywords:  Asphyxia; Electroencephalography.; Magnetic Resonance Imaging; Nitric Oxide; Phenobarbital

Year:  2016        PMID: 27602186      PMCID: PMC4996962          DOI: 10.5001/omj.2016.67

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  29 in total

1.  Role of carbon monoxide and nitric oxide in newborn infants with postasphyxial hypoxic-ischemic encephalopathy.

Authors:  Hendrik J Vreman; Ronald J Wong; David K Stevenson; Rolf R Engel
Journal:  Pediatrics       Date:  2002-04       Impact factor: 7.124

2.  Is phenobarbital a neuroprotective agent in newborn infants with perinatal asphyxia?

Authors:  Nilay Hakan; Mustafa Aydin; Osman Yilmaz; Aysegul Zenciroglu; Nurullah Okumus
Journal:  Pediatr Int       Date:  2014-02       Impact factor: 1.524

3.  Hypoxic Ischemic Encephalopathy: Pathophysiology and Experimental Treatments.

Authors:  Kimberly A Allen; Debra H Brandon
Journal:  Newborn Infant Nurs Rev       Date:  2011-09-01

4.  Selective inhibition of inducible nitric oxide synthase reduces neurological deficit but not cerebral edema following traumatic brain injury.

Authors:  G Louin; C Marchand-Verrecchia; B Palmier; M Plotkine; M Jafarian-Tehrani
Journal:  Neuropharmacology       Date:  2005-10-19       Impact factor: 5.250

5.  Nonlinear mixed effects modelling approach in investigating phenobarbital pharmacokinetic interactions in epileptic patients.

Authors:  Katarina Vučićević; Marija Jovanović; Bojana Golubović; Sandra Vezmar Kovačević; Branislava Miljković; Žarko Martinović; Milica Prostran
Journal:  Eur J Clin Pharmacol       Date:  2014-11-09       Impact factor: 2.953

6.  Effect of high-dose phenobarbital on oxidative stress in perinatal asphyxia: an open label randomized controlled trial.

Authors:  Geeta Gathwala; Ashish Marwah; Veena Gahlaut; Poonam Marwah
Journal:  Indian Pediatr       Date:  2010-11-30       Impact factor: 1.411

7.  Adverse effects of early phenobarbital administration in term newborns with perinatal asphyxia.

Authors:  O A Ajayi; O T Oyaniyi; U D Chike-Obi
Journal:  Trop Med Int Health       Date:  1998-07       Impact factor: 2.622

Review 8.  Perinatal hypoxic-ischemic encephalopathy.

Authors:  Ming-Chi Lai; San-Nan Yang
Journal:  J Biomed Biotechnol       Date:  2010-12-13

Review 9.  Perinatal asphyxia: current status and approaches towards neuroprotective strategies, with focus on sentinel proteins.

Authors:  Mario Herrera-Marschitz; Paola Morales; Lisette Leyton; Diego Bustamante; Verena Klawitter; Pablo Espina-Marchant; Camilo Allende; Francisco Lisboa; Gabriel Cunich; Antonella Jara-Cavieres; Tanya Neira; Manuel A Gutierrez-Hernandez; Victor Gonzalez-Lira; Nicola Simola; Andrea Schmitt; Micaela Morelli; R Andrew Tasker; Peter J Gebicke-Haerter
Journal:  Neurotox Res       Date:  2010-07-20       Impact factor: 3.911

10.  Antibacterial, antiurease, and antioxidant activities of some arylidene barbiturates.

Authors:  Bahar Bilgin Sokmen; Serpil Ugras; Hasan Yucel Sarikaya; Halil Ibrahim Ugras; Refiye Yanardag
Journal:  Appl Biochem Biotechnol       Date:  2013-09-11       Impact factor: 2.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.